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Abstract. – OBJECTIVE: Coronary artery by-
pass grafting (CABG) seems to present a power-
ful trigger of oxidative stress (OS) and acute in-
flammatory response. This study aimed to esti-
mate the effects of off-pump coronary artery by-
pass (OPCAB) grafting on the OS that is com-
monly observed in patients undergoing opera-
tion under cardiopulmonary bypass (CPB). Ad-
ditionally, we aimed to examine the relationship 
between and paraoxonase 1 (PON1) activity and 
the degree of stenosis, severity and complexity 
of the atherosclerotic lesions, estimated by SYN-
TAX score (SS). 
PATIENTS AND METHODS: Study group of 107 
patients scheduled for CABG were divided into 
CPB and OPCAB group. Blood samples for OS 
markers measurement were collected at six-time 
intervals: before skin incision (t1), immediately 
after surgery (t2), 6h (t3), 24h (t4), 48h (t5) and 
96h after cessation of the operation and surgical 
trauma (t6). SS was calculated. 
RESULTS: A significant decrease in lipid hy-
droperoxides (LOOH) and advanced oxidation 
protein products (AOPP) levels after both types 
of surgeries were observed, whereas PON1 re-
duction was observed higher in the CPB than in 
the OPCAB group.
A significant inverse correlation between SS 
values and PON1 activity, preoperatively and 
during the early postoperative hours after surgery 
[in t2, t3 time intervals (p<0.05 for all)] was found. 
ROC analysis showed that for CPB patients, Model 
with all OS parameters showed excellent accuracy 
(AUC=0.957, p<0.001) for prediction postoperative 
complications.
CONCLUSIONS: Decrease in PON1 activity 
during the early post-operative phases was re-
lated to higher SS. This relationship was more 
convincing in CPB, compared with OPCAB pa-
tients. Moreover, integrated models of OS status 
parameters have the capability to predict the de-
velopment of postoperative complications.
Key Words:
Atherosclerosis, Oxidative stress, Paraoxonase 1, 
SYNTAX score.
Introduction
In cardiac surgery, the cardiopulmonary bypass 
(CPB) pump has been recognized as the main cause 
of an oxidative stress (OS) and complex systemic 
inflammatory response1. The OS and inflamma-
tory response to CPB initiate through contact be-
tween heparinized blood and non-endothelial cell 
surfaces of the CPB circuit. Termination of cardio-
plegic arrest by reperfusion leads to additional OS 
development, contributing to the complex patho-
physiology of ischemia-reperfusion injury2,3. 
Off-pump coronary artery bypass grafting 
(OPCAB) on the beating heart reduces the OS and 
acute inflammatory response but does not com-
pletely prevent it4,5. The avoidance of CPB and 
myocardial ischemia-reperfusion injury has been 
proposed to significantly reduce the postoperative 
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complications6,7. Our previous related study8 has 
explicitly confirmed mutual involvement of OS 
and inflammation in atherosclerosis development, 
during the entire course of the disease.
The pathological milieu in cardiovascular dis-
ease leads not only to increase in OS and inflam-
matory markers in circulation9-15, but also leads 
to reduction of antioxidative defense system13,16-18. 
Serum paraoxonase 1 (PON1) is an enzyme with 
the capacity to combat against lipid peroxidation in 
endothelial cells, macrophages and lipoproteins17. 
Namely, PON1 possess numerous atheroprotective 
properties, which include preserving high density 
lipoprotein (HDL) function, stimulation of choles-
terol efflux, as well as anti-inflammatory and anti-
oxidant activities. PON1 also exhibits anti-adhesive, 
anti-thrombotic and anti-apoptotic effects17. More-
over, PON genetic polymorphisms are regarded as 
contributors to susceptibility/protection from ath-
erosclerosis-related diseases19,20. However, an exten-
sive interest exists recently in disclosing the role of 
PON1 regarding different human disorders17,21.
Furthermore, lipid peroxidation and protein 
oxidation involvement in association with CPB 
surgery are not fully understood. This is proba-
bly related to the assessment of reperfusion injury 
due to the limitation in available methods for in 
vivo measurement of free radical generation or 
end products of free radical-catalyzed oxidation 
of lipids and proteins22,23. In line with this, lipid 
hydroperoxides (LOOH) and advanced oxidation 
protein products (AOPP) are used to evaluate the 
effect of reactive oxygen species on lipid and pro-
tein structures, respectively22,23. 
The aim of this study was to examine a possible 
relationship between PON1 activity and the degree 
of stenosis, severity and complexity of the athero-
sclerotic lesions of the coronary arteries, estimated 
by SYNTAX score (SS)24. Present project estimat-
ed the effects of OPCAB operations on the OS (i.e., 
LOOH and AOPP) markers and PON1 activity that 
are commonly affected in patients undergoing op-
eration under CPB. These measurements could be 
finally proved as potential, beneficial and auxilia-
ry argument for the surgical decision and the final 
choice of operative technique.
Patients and Methods
Patients
We carried out a prospective cohort study at the 
Medical Military Academy, Belgrade (Department 
for Cardiac Surgery). Biomarkers of oxidative stress 
were measured at the Faculty of Pharmacy (Depart-
ment for Medical Biochemistry), University of Bel-
grade. The Hospital Ethics Committee approved the 
project protocol. All patients that were included in 
the study signed fully informed consent.
The present study consisted of 107 patients 
scheduled for a coronary artery bypass grafting 
(CABG). The patients encompassed two groups: 
the CPB group (n=60), where subjects under-
went CABG using CPB on the potassium arrested 
heart, and the OPCAB group (n=47), where sub-
jects underwent CABG on the beating-heart with-
out using CPB.
Patients with acute infections, immunologic or 
malignant diseases, immunosuppressive medica-
tions usage, recent myocardial infarction (in the 
last three months), chronic renal failure, reopera-
tion, perioperative myocardial infarction, massive 
mediastinal bleeding after surgical procedure, 
heart failure, and previous stroke or transient 
ischemic attack were excluded.
The SYNTAX Score (SS)24 was preoperatively 
calculated for all patients.
The SS is a powerful coronary score for pre-
diction events after percutaneous coronary inter-
vention24. Accordingly, all patients were divided 
into 3 subgroups: low (i.e., SS <22), intermedi-
ate (i.e., SS between 23 and 30) and high SS (i.e., 
SS>30).
Anesthesia 
All patients underwent standardized anesthet-
ic technique. Etomidate (0.1-0.2 mg/kg), sufen-
tanyl (0.5-1 μg/kg) and rocuronium (1 mg ⁄kg) 
were induced for each patient. Also, sevoflurane 
(0.6-1.0%) and sufentanyl (0.5-1 μg/kg/h) were 
used for maintenance of general anesthesia.
Surgical Procedure
Midline sternotomy and harvesting of left in-
ternal mammary artery (a pedicle and saphenous 
vein grafts) were performed after full exposure 
of the coronary artery branches for its revascu-
larisation. 
CPB group
Ascending aortic cannulation and two-stage 
venous cannulation in the right atrium were used 
for CABG using a CPB pump. A roller pump 
(Stockert-S5, Sorin Group, Munich, Germany) 
and oxygenator (low-prime) accompanied with an 
incorporated cardiotomy reservoir (Sorin Inspire 
8, Sorin Group, Mirandola, Italy) were used for 
the CPB circuit. The non-pulsatile pump flow (i.e., 
PON1 and SYNTAX score in CAD
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at 2.2-2.4 L/min/m2) and perfusion pressure (i.e., 
between 50-80 mmHg) during CPB were kept. 
The homemade cold potassium cardioplegia (i.e., 
temperature of 4°C) was used to achieve myocar-
dial protection. On the arrested heart all distal 
anastomoses of the bypass grafts were done.
OPCAB group
The Starfish™ 2 Heart Positioner (Medtron-
ic, Inc., Minneapolis, MN, USA) and the Octo-
pus® IV Tissue Stabilizer were used to maintain 
the mechanical stability of the coronary arteri-
otomy area. Myocardial protection was main-
tained by the soft plastic intraluminal coronary 
flow-shunt (Medtronic, Clearview®, Medtronic, 
Inc., Minneapolis, MN, USA). The latter one 
was passed into the coronary arteriotomy for 
the whole time aiming to prevent ischemia of 
myocardium during placing of distal anastomo-
sis. All of the anastomoses were done on the 
beating heart.
Sample Collection and Analyses
Six-time intervals (t1-t6) were determined 
for collection of blood samples. The phlebotomy 
was performed following the protocol (i.e., from 
the central venous line through jugular internal 
vein). After centrifugation (i.e., 3000 rpm for 15 
minutes) sera were separated and stored at -80°C, 
until analysis.
Blood collection was performed before the in-
cision of the skin (t1), immediately after the sur-
gery (t2), 6h (t3), 24 h (t4), 48h (t5) and 96 h after 
termination of the operation and surgical trauma 
(t6). Sample collection procedure was the same 
for OPCAB and CPB groups.
Measurement of Oxidative Stress (OS) 
Status Parameters
LOOH were determined using the method of 
Gay and Gebicki. The procedure is based on the 
use the ferric-xylenole-orange method, after pre-
cipitation in perchloric acid25. The Witko-Sarsat 
method was applied for AOPP measurement. The 
method is based on the reaction of glacial acetic 
acid and potassium iodide23. Paraoxon (Chem 
Service Inc, West Chester, PN, USA) as a sub-
strate was used for kinetic measurement of the 
serum PON1 activity, following the instructions 
of the method of Richter and Furlong26. The Ell-
man’s method27 with dinitrodithiobenzoic acid 
as a reagent in alkaline buffer was applied for 
the measurement of total SH groups (tSHG). 
All OS status parameters were measured on an 
ILAB 650 analyzer (Instrumentation Laborato-
ry, Milan, Italy).
Statistical Analysis
Statistical analysis was performed using SPSS 
statistical package (version 18.0 for Windows, 
SPSS Inc., Chicago, IL, USA). Data are presented 
as mean±standard deviation (SD), median (inter-
quartile range), or counts and percentages (%). 
Differences between groups were evaluated with 
ANOVA repeated measures as the non-parametric 
Friedman test, followed by the Wilcoxon signed-
rank test, Kruskal-Wallis non-parametric analy-
sis of variance, followed with the Mann-Whitney 
U test. Chi-square test was used to analyze the 
differences between categorical data. A correla-
tion analysis with Spearman’s (ρ) correlation co-
efficient was used to determine the relationships 
between variables. Multiple linear regression 
(MLR) analysis was performed to estimate clini-
cal and general factors that could influence PON1 
activity. The starting model of parameters con-
sisted of the following variables: SYNTAX score, 
hypertension status, diabetes, peripheral arterial 
disease, smoking status, family history of coro-
nary artery disease, acute myocardial infarction, 
hyperlipidemia, BMI, gender and age. Receiver 
Operating Characteristic (ROC) curve analysis 
was used to test the discriminatory potential of 
OS status parameters in predicting postoperative 
complications. In all analyses, a p-value < 0.05 
was considered as statistically significant.
Results
Table I shows basic characteristics of the cor-
onary artery disease patients, immediately before 
them underwent the surgical procedure. The study 
group consisted mainly of males. Among patients 
undergoing elective CABG surgery the high-
est percent was those of overweight (50.5%) and 
obese (29.0%) patients. The majority of patients 
were also hypertensive (87.9%), hyperlipidemic 
(66.4%) with a positive family history of coronary 
artery disease (74.8%). A minor percentage had 
diabetes mellitus type 2 (31.8%). Additionally, a 
high percent of patients were smokers (71.0%). 
Data on their long-term medication are also pre-
sented in Table I. 
This project assessed up to four oxidative sta-
tus parameters (i.e., LOOH, AOPP, PON1, and 
tSHG) in order to get a more precise insight into 
the redox balance before and its changes after 
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CABG surgery. Moreover, we estimated possi-
ble differences between the two distinct surgical 
procedures, CPB and OPCAB, regarding OS de-
velopment. In this acute situation non-parametric 
ANOVA repeated measures (Friedman’s test fol-
lowed by Wilcoxon’s signed rank test as post-hoc 
test) enabled us to compare OS parameters at dif-
ferent time intervals, as well as between surgical 
modalities at the same time. Results are presented 
in Figure 1.
A significant decrease in LOOH and AOPP 
concentrations after both types of surgeries was 
observed.
These experiments showed also a significant 
decrease of both antioxidative parameters, PON1 
activity and tSHG concentration as representatives 
of enzymatic and non-enzymatic parts of the endog-
ene antioxidative defence system. PON1 reduction 
was observed higher in the CPB than in the OPCAB 
group. Thus, we performed further analysis to find a 
possible explanation for above discrepancy.
To assess the mutual involvement of cor-
onary vessel occlusion reflected through the 
preoperative SS value and surgery type on 
PON1 activity in distinct pre- and postopera-
tive points, we performed a non-parametric 
Kruskal-Wallis ANOVA test, followed by the 
Mann-Whitney U test for inter-groups compar-
ison, in sub-groups according to surgical mo-
dality and SS cut-off values of 22 and 30 points. 
More precisely, we compared a CPB subjects 
with a OPCAB subjects having the same level 
of coronary vessel occlusion, i.e., sub-groups 
with low SS – below 22, intermediate SS level 
(23-30 points) and high SS – above 30 points, 
as determined by tertile value boundaries for 
this current group of patients. The results are 
presented in Figure 2.
Obtained results showed a significantly higher 
PON1 activity in the OPCAB group with an inter-
mediate SS level compared with the CPB group 
with the same level of plaque severity, and this 
was true for the t2-t5 study points (Figure 2).
More important was the slight but, relatively 
constant increase in PON1 activity in subjects 
with the highest level of coronary artery stenosis. 
Table I. General and clinical characteristics of the study population.
*parameters with non-normal distribution; Data shown as means (SD), median (25th -75th percentile), or numbers (%)
Variable Study group
  Age, (years) 64.1±9.6
  Gender (m/f), n (%) 81/26 (75.7/24.3)
  BMI (kg/m2)* 27.6 (25.3-30.7)
Clinical data
  Obesity- lean/overweight/obese, n (%) 22/54/31 (20.6/50.5/29.0)
  Hypertension, n (%) 94 (87.9)
  Diabetes mellitus type 2, n (%) 34 (31.8)
  Hyperlipidemia, n (%) 71 (66.4)
  Chronic obstructive pulmonary disease, n (%) 12 (11.2)
  Chronic Renal Failure, n (%) 6 (5.6)
  Acute myocardial infarction, n (%) 62 (57.9)
  Peripheral arterial disease, n (%) 47 (43.9)
  Smoking, n (%) 76 (71.0)
  Family history of coronary artery disease, n (%) 80 (74.8)
  Left ventricular ejection fraction, %* 50.0 (45.0-55.0)
  SYNTAX Score (points) 27.1±10.3
Therapy
  β-blockers, n (%) 102 (95.3)
  ACE inhibitors, n (%) 94 (87.9)
  Calcium-antagonists, n (%) 36 (33.6)
  Nitrates, n (%) 95 (88.8)
  Statins, n (%) 76 (71.0)
  Oral antidiabetics, n (%) 22 (20.6)
  Diuretics, n (%) 36 (33.6)
PON1 and SYNTAX score in CAD
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Figure 1. Changes in oxidative stress 
parameters during CABG surgery, for 
two surgical procedures until 96h post-
operatively: t1-before skin incision, t2- 
after protamine-sulfate administration, 
t3- 6h, t4-24h, t5-48h, t6-96h after oper-
ations.*,**,***p<0.05, <0.01, <0.001 vs. 
basal value (before surgery – t1), a, aa,aaa 
– p<0.05, <0.01, <0.001  CPB vs. OPCAB 
at the same time point.
Figure 2. PON1 (U/L) activity in different time points before and after CPB and OPCAB surgery according to SYNTAX 
Score tertile value subgroups (low SS ≤ 22, intermediate SS 23-30 and high SS ≥30); a-p <0.05 vs. low SS group, b-p <0.05 vs. 
intermediate SS group; *, **p<0.05, <0.01 OPCAB vs. CPB in the same SYNTAX score subgroup, Kruskall-Wallis test and 
subsequent Mann-Whitney U test - *&-borderline significance (0.05< p <0.100).
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This was more evident, and from the first study 
point in the CPB group (Figure 2). 
In order to confirm the possible influence 
of coronary vessel wall stenosis level on sys-
temic PON1 activity we conducted Spearman’s 
non-parametric correlation analysis. The results 
are presented in Figure 3.
As Figure 3 shows, the SS level was significantly 
and inversely correlated with PON1 activity before 
surgery and the first two times after the surgery t2 
and t3; after 24h this correlation was not observed. 
The other oxidative status parameters also showed 
correlations with SS level, as follows: LOOH (t2, 
t4, t5) and AOPP (t2) showed significant positive 
correlation with SS, whereas tSHG was negatively 
correlated with SS (t1, t3, t4). 
MLR (backward selection) enabled us to get 
the best model of parameters which could explain 
the diminishing PON1 activity in coronary ar-
tery disease patients in general, and upon surgical 
conditions (Table II).
When we analyzed the whole group of pa-
tients, irrespective of the surgery modality, MLR 
revealed SS and BMI to be the main determinants 
of PON1 activity. Considering the significant 
negative correlation between SS value and PON1 
activity, it is reasonable to suppose that athero-
sclerotic plaque aggravation causes a reduction 
in PON1 activity. This was the true for each of 
the six time points. The same analysis within the 
CPB group detected mainly BMI as a significant 
PON1 activity predictor. In OPCAB group we 
found peripheral arterial disease as a main factor 
for the variability in PON1 activity before surgi-
cal procedure, so as after that.
Furthermore, we performed ROC analysis for 
all CABG patients combined and separately for 
the CPB group to test the clinical accuracy of ox-
idative status parameters in predicting postoper-
ative complications (Figure 4). Twelve postopera-
tive complications were noted in the CPB group, 
and three in the OPCAB group. The three Models 
were constructed consisting of pro-oxidant pa-
rameters (i.e. LOOH and AOPP-Model 1), antiox-
idative parameters (i.e. PON1 and tSHG-Model 2) 
and all four OS parameters (Model 3). Logistic 
regression analysis showed that the Model 2 ROC 
curve had very good discriminatory capability 
(AUC=0.828, p<0.001)28. Model 3 had the best 
clinical accuracy in the CPB group-all OS param-
eters integrated by logistic regression analysis 
(excellent accuracy, i.e., AUC=0.957, p<0.001). 
Discussion
Our current study revealed several important 
findings. Generally, we reported the post-oper-
ative reduction in concentrations of LOOH and 
AOPP in patients with coronary artery disease 
(Figure 1). We also found higher LOOH and 
AOPP levels in the CPB, as compared with OP-
CAB group during the post-operative period, 
showing that OS was greater in the CPB group 
which could be explained by more severe condi-
tions of the CPB patients or their decreased capa-
bility to respond to the OS challenge.
Several research groups29,30 detected that lip-
id peroxides are generated during CABG surgery 
undergoing the β-scission reaction31. This process 
Figure 3. Correlation between PON1 activities at different time points during CABG surgery and preoperative SYNTAX 
Score values. Spearman’s (ρ) and p values are shown on the graphs (*p<0.05).
PON1 and SYNTAX score in CAD
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results in the formation of gaseous carbon-hy-
drogen species, which as volatile substances are 
exhaled almost immediately upon formation. 
Cristescu et al32 showed that CPB conditions led 
to higher increases in exhaled gas than with the 
OPCAB procedure, but within a shorter period 
of time, according to procedural specificity. CPB 
caused more peaks in ethylene evolution than OP-
CAB, i.e., more aspects of the CPB procedures 
can lead to lipid peroxidation compared with pro-
cedures in OPCAB surgery32. Thus, our results 
are in line with those presented in their study32 
regarding higher OS and reduced antioxidative 
protection seen in CPB patients. 
AOPP is a measure of oxidized proteins, main-
ly albumin33. Albumin concentration was found 
to decrease34 as the acute phase reaction develops, 
knowing that it is a negative acute response reac-
Table II. Multiple linear regression analysis of clinical factors’ influence on PON1 activity.
Legend: Unstandardized β coefficients (SE), 95% Confidence Interval and P values for the parameters in the best-fit model for 
the association of several parameters with PON1 activity, backward selection. PON1, paraoxonase 1; SYNTAX Score, synergy 
between percutaneous coronary intervention with taxus and cardiac surgery score; BMI, body mass index; CPB, cardiopulmonary 
bypass; OPCAB, off-pump coronary artery bypass.
 The best The best Unstandardized 95%
 model model Coefficients Confidence p
 Adjusted R2 Variables Beta (SE) Interval for β
All patients PON1
    t1 0.221 Syntax Score –3.30 (0.86) -5.0– -1.6 <0,001
  BMI 7.00 (2.30) 2.3 – 11.6 0.004
    t2 0.188 Syntax Score -3.00 (0.76) - 4.5 – -1.5 <0.001
  BMI 4.10 (2.10) 0.03-8.25 0.049
   t3 0.162 Syntax Score -2.62 (0.70) -4.0 – 1.2 <0.001
  BMI 3.40 (1.50) -0.38 –7.30 0.076
   t4 0.110 Syntax Score -1.88 (0.68) -3.23 – 0.56 0.007
  BMI 3.71 (1.85) 0.013 –7.40 0.049
   t5 0.158 Syntax Score -2.52 (0.69) -3.91 – -1.12 0.001
  BMI 3.62 (1.91) -0.178 –7.42 0.062
   t6 0.116 Syntax Score -2.06 (0.69) -3.43 –0.68 0.004
  BMI 3.39 (1.88) -0.35 – 7.14 0.075
CPB group PON1
   t1 0.202 BMI 9.44 (2.83) 3.72-15.16 0.002
   t2 0.266 BMI 7.13 (2.21) 2.66-11.61 0.003
  Age -1.86 (0.95) -3.78 –0.062 0.057
   t3 0.153 BMI 4.97 (1.73) 1.47-8.46 0.007
   t4 0.252 BMI 7.55 (1.99) 3.54 – 11.57 <0.001
   t5 0.283 BMI 8.03 (1.93) 4.07-11.99 <0.001
   t6 0.288 BMI 6.74 (1.68) 3.34-10.15 <0.001
  Hyperlipidemia -23.5 (13.7) -51.2 – -4.34 0.095
OPCAB group PON1
   t1 0.277 Hypertension -58.8 (31.6) -123.2–5.61 0.072
  Peripheral arterial disease -67.6 (23.7) -116.0– -19.3 0.008
     Smoking -55.5 (25.1) -106.6– -4.3 0.034
   t2 0.136 Peripheral arterial disease -57.3 (22.8) -103.6– -11.0 0.017
   t3 0.292 Peripheral arterial disease -48.5 (20.4) -90.2– -6.8 0.024
    Age -3.11 (1.1) -5.3– -0.897 0.007
   t4 0.027 Peripheral arterial disease -28.5 (20.4) -70.0-13.1 0.172
   t5 0.131 Peripheral arterial disease -48.7 (21.6) -92.6– -4.7 0.031
  Hypertension -49.5 (28.6) -107.8 – -8.8 0.093
   t6 0.035 Peripheral arterial disease -34.8 (23.3) -82.2 – 12.5 0.144
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tant. This could explain the AOPP decrease after 
the CABG surgery in our study.
As previously reported, it has been established 
that low PON1 activity is connected with a possi-
ble coronary artery disease development35,36, and 
we have shown that this is certainly the case for 
the Serbian population18.
Results regarding plaque complexity (i.e., 
through SS value) and surgery modality (i.e., CPB 
vs. OPCAB) revealed the mutual involvement of 
these two specificities of this current study. Thus, in 
the present study we demonstrated decreased PON1 
activity in CPB patients with advanced stenosis (i.e., 
intermediate level – 22-30 SS values) compared 
with OPCAB subjects with the same level of steno-
sis. These findings are convincing data, since these 
two-time intervals were the earliest times after the 
surgery termination (up to 6h). Therefore, we could 
suppose that these must be most closely connected 
with each of the two surgery specificities. A sim-
ilar relationship between PON1 activity and an-
giographic severity of coronary artery disease was 
found by Granér et al37.
Our results indicated also a decrease in PON1 
activity together with increase in vessel wall plaque 
complexity comparing low with moderate SS, and 
especially and consistently in the CPB group.
Low PON1 activities reported in our research 
could suggest a more exhausted antioxidative ca-
pability in our patients and a possible threat for 
the development of post-operative complications 
over a prolonged period, and post-operative com-
plications that were noted during the subsequent 
patients’ stay in hospital. This implies a need for 
more thorough monitoring of patients with the low-
est PON1 activities (e.g., the lower tertile value for 
our CPB group was 52 U/L and 85 U/L for the OP-
CAB group at sampling time t2, when the lowest 
activities were found). These lower tertile values 
suggest that a huge impairment in this protective 
enzyme activity occurred. In our previous study 
we have observed this order of magnitude of low 
Figure 4. ROC curves of the discriminatory ability of selected parameters regarding postoperative complications in all CABG 
patients, and in the CPB group.
Legend: AUC, area under the curve; CABG, coronary artery bypass grafting; LOOH, lipid hydroperoxides; AOPP, advanced 
oxidatiom protein product; PON1, paraoxonase 1; tSHG, total sulfhydril group; OS, oxidative stress.
Table III. Area under the curve, 95% Confidence Interval and Standard error for the selected Models' discriminatory ability 
regarding postoperative complications presence in CABG group and CPB, respectively.
 AUC (SE) p 95% Confidence Interval
CABG group
   Model LOOH/AOPP 0.704 (0.066) 0.012 0.574-0.833
   Model PON1/tSHG 0.828 (0.050) <0.001 0.730-0.926
   Model All OS parameters 0.599 (0.066) 0.222 0.469-0.728
CPB group
   Model LOOH/AOPP 0.733 (0.077) 0.013 0.582-0.883
   Model PON1/tSHG 0.832 (0.065) 0.000 0.703-0.960
   Model All OS parameters 0.957 (0.034) 0.000 0.890-1.023
PON1 and SYNTAX score in CAD
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PON1 values in a group of acute ischemic stroke 
patients, immediately after hospital admission38.
The SS value was also significantly and inverse-
ly correlated with PON1 activity at the beginning, 
as well as during the early postoperative hours after 
surgery. This correlation was present 24 h post-op-
eration (t4) but was not present later, probably be-
cause of the activation of other homeostatic factors 
which could influence PON1 activity and/or its 
polymorphisms. Moreover, a relationship between 
SS and other OS parameters at some sampling oc-
casions (i.e., positive correlations with LOOH and 
AOPP and negative with tSHG) was shown. The 
direct correlation between OS markers (i.e., AOPP 
and LOOH) with preoperative SS values and in-
verse correlation of PON1 and tSHG with the same 
measure of blood vessel stenosis could clearly im-
ply a general connection between atherosclerotic 
plaque severity and redox disbalance.
Although the frequency of postoperative com-
plications in cardiac surgery have been substan-
tially reduced during the past decade, the del-
eterious clinical status of patients, reflected as 
surgery-related disturbances, is still remained the 
main problem in this area, and the general cause 
of mortality in coronary artery disease patients39. 
Out of 107 CABG patients, 15 developed postop-
erative complications (i.e., 12 in the CPB group 
and 3 in the OPCAB group) and the most im-
portant complications were: pleural effusion, leg 
wound infection, shallow sternal wound infection 
and pulmonary thromboembolism.
Finally, ROC analysis enabled us to estimate 
the clinical reliability of OS status markers in pre-
dicting the development of postoperative compli-
cations. Construction of logistic regression mod-
els showed that for all CABG patients, the Model 
2 ROC curve, integrating both antioxidative pa-
rameters and all their sampling occasions, had 
very good discriminatory capability (AUC=0.828, 
p<0.001)28. In the CPB group alone, the model 
with the best clinical accuracy was Model 3, with 
all OS parameters included (excellent accuracy, 
i.e., AUC=0.957, p<0.001).
Several limitations17,40 of this investigation 
needs to be acknowledged. We were not able to 
provide data for HDL particles which are carri-
ers for PON1. HDL particles differ in size, den-
sity, structure, and metabolic function. Namely, 
chronic inflammatory state such as coronary ar-
tery disease may induce major changes in HDL 
function and structure. This condition may fur-
ther compromise HDL’s atheroprotective role, 
which can be, at least in part, related to chang-
es in PON1 and loss of its antioxidant capability 
and might affect the results of the current study17. 
Additionally, this was a single-center study, and a 
relatively small number of patients were included. 
Thus, multicentric studies with larger number of 
patients are needed to confirm our results.
Conclusions
The significant decrease in PON1 during 
the early post-operative phases were related to 
the atherosclerosis status of patients estimated 
through the SS as a quantitative measure of cor-
onary artery stenosis severity and complexity. 
This relationship was more convincing in CPB, 
compared with OPCAB patients, having on the 
one hand higher SS levels, and more complicated 
surgery conditions on the other. Integrated mod-
els of OS status parameters have the capability to 
predict the development of postoperative compli-
cations, which suggests an extra need for further 
development and implementation of OS biomark-
ers in different fields of clinical practice. This 
could be the case for cardiac surgery area that at 
the end of the day could substantially influence 
patients’ post-surgery outcome.
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